CSB 2.010 Note(mm) Quazepam;
CSB 2.010 Note(6) Paragraph (km) of s. 161.18 (3), Stats., is created to read: CSB 2.010 Note(km) Tiletamine and Zolazepam or any salt thereof;
CSB 2.010 Note(7) Paragraph (a) of s. 161.16 (3), Stats., is renumbered to read:
CSB 2.010 Note(am) Alphaprodine;
CSB 2.010 Note(8) Paragraph (a) of s. 161.16 (3), Stats., is created to read: CSB 2.010 Note(a) Alfentanil;
CSB 2.010 Note(9) Paragraph (rg) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(rg) MPPP 1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.010 Note(10) Paragraph (vg) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(vg) (PEPAP) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;
CSB 2.010 Note(11) Paragraph (b) of s. 161.16 (10), Stats., is created to read: CSB 2.010 Note(b) Nabilone (another name for nabilone: (+)-trans-3- (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1- hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one).
CSB 2.010 Note(12) Subsection (2) of s. 161.14, Stats., is amended to read: CSB 2.010 Note(2) Opiates. Unless specifically excepted under federal regulations or unless listed in another schedule, any of the following opiates, or their isomers, esters, ethers, salts, salts of isomers, esters of ethers, if isomers, esters, ethers, salts or salts of isomers exist within the specified chemical designation (for purposes of par. (tg) only, the term isomer includes the optical and geometric isomers):
CSB 2.010 Note(13) Paragraph (a) of s. 161.14 (2), Stats., is renumbered to read:
CSB 2.010 Note(ag) Acetylmethadol;
CSB 2.010 Note(14) Paragraph (a) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.010 Note(15) Paragraph (cg) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(cg) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.010 Note(16) Paragraph (dg) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl) -4-piperidinyl]-N-phenylpropanamide);
CSB 2.010 Note(17) Paragraph (rj) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(rj) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.010 Note(18) Paragraph (tg) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(tg) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl]propanamide);
CSB 2.010 Note(19) Paragraph (xm) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(xm) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);
CSB 2.010 HistoryHistory: Cr. Register, February, 1988, No. 386, eff. 3-1-88. CSB 2.010 NoteCSB 2.20 Addition of beta-hydroxy-3-methylfentanyl to schedule I. Paragraph (er) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(er) Beta-hydroxy-3-methylfentanyl.
CSB 2.010 HistoryHistory: Cr. Register, July, 1989, No. 403, eff. 8-1-89. CSB 2.010 NoteCSB 2.21 Additions, deletions, corrections, transfers, and amendments to drug schedules. (1) Subsection (1) of s. 161.14, Stats., is amended to read: CSB 2.010 Note(1) Included substances. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I.
CSB 2.010 Note(2) Paragraph (a) of s. 161.14 (2), Stats., is amended to read: CSB 2.010 Note(a) Acetyl-alpha-methylfentany (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.010 Note(3) Paragraph (er) of s. 161.14 (2), Stats., is amended to read: CSB 2.010 Note(er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2- phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.010 Note(4) Paragraph (rg) of s. 161.14 (2), Stats., is amended to read: CSB 2.010 Note(rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.010 Note(5) Paragraph (qs) of s. 161.14 (2), Stats., is amended to read: CSB 2.010 Note(qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
piperidinyl]-N-phenylpropanamide);
CSB 2.010 Note(6) Paragraph (tg) of s. 161.14 (2), Stats., is amended to read: CSB 2.010 Note(tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
CSB 2.010 Note(7) Paragraph (vg) of s. 161.14 (2), Stats., is amended to read: CSB 2.010 Note(vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
CSB 2.010 Note(8) Paragraph (xm) of s. 161.14 (2), Stats., is amended to read: CSB 2.010 Note(xm) Thiofentanyl (N-[1-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide);
CSB 2.010 Note(9) Paragraph (cd) of s. 161.14 (2), Stats., is created to read: CSB 2.010 Note(cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
CSB 2.010 Note(10) Paragraph (e) of s. 161.14 (3), Stats., is amended to read: CSB 2.010 Note(e) Codeine-N-oxide;
CSB 2.010 Note(11) Paragraph (j) of s. 161.14 (3), Stats., is amended to read: CSB 2.010 Note(j) Etorphine, except its hydrochloride salts;
CSB 2.010 Note(12) Paragraph (s) of s. 161.14 (3), Stats., is amended to read: CSB 2.010 Note(s) Morphine-N-oxide;
CSB 2.010 Note(13) Paragraph (a) of s. 161.14 (4), Stats., is amended to read: CSB 2.010 Note(a) 3,4-methylenedioxyamphetamine, commonly known as “MDA”;
CSB 2.010 Note(14) Paragraph (b) of s. 161.14 (4), Stats., is amended to read: CSB 2.010 Note(b) 5-methoxy-3,4-methylenedioxyamphetamine;
CSB 2.010 Note(15) Paragraph (c) of s. 161.14 (4), Stats., is amended to read: CSB 2.010 Note(c) 3,4,5-trimethoxyamphetamine;
CSB 2.010 Note(16) Paragraph (ag) of s. 161.14 (4), Stats., is created to read: CSB 2.010 Note(ag) 3,4-methylenedioxyethylamphetamine, commonly known as “MDE”;
CSB 2.010 Note(17) Paragraph (ar) of s. 161.14 (4), Stats., is created to read: CSB 2.010 Note(ar) N-hydroxy-3,4-methylenedioxyamphetamine;
CSB 2.010 Note(18) Paragraph (u) of s. 161.14 (4), Stats., is amended to read: CSB 2.010 Note(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
CSB 2.010 Note(19) Paragraph (ud) of s. 161.14 (4), Stats., is created to read: CSB 2.010 Note(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
CSB 2.010 Note(20) Paragraph (ur) of s. 161.14 (4), Stats., is amended to read: CSB 2.010 Note(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
CSB 2.010 Note(21) Paragraph (d) of s. 161.14 (7), Stats., is created to read: CSB 2.010 Note(d) 4-methylaminorex, including its salts and salts of isomers;
CSB 2.010 Note(22) Paragraph (e) of s. 161.14 (7), Stats., is created to read: CSB 2.010 Note(e) N,N-dimethylamphetamine, including its salts and salts of isomers.
CSB 2.010 Note(23) Paragraph (L) of s. 161.14 (7), Stats., is created to read: CSB 2.010 Note(L) methcathinone, including its salts and salts of isomers.
CSB 2.010 Note(24) Subdivision 4m of s. 161.16 (2) (a), Stats., is created to read: CSB 2.010 Note4m. Dihydrocodeine;
CSB 2.010 Note(25) Paragraph (d) of s. 161.16 (3), Stats., is repealed.
CSB 2.010 Note(26) Paragraph (am) of s. 161.16 (7), Stats., is created to read: CSB 2.010 Note(am) Glutethimide;
CSB 2.010 Note(27) Subsection (9) of s. 161.16, Stats., is repealed.
CSB 2.010 Note(28) Subsection (20m) of s. 161.01, Stats., is created to read: CSB 2.010 Note(20m) (a) “Anabolic steroid” means any drug or hormonal substance, chemically or pharmacologically related to testosterone (except estrogens, progestin, and corticosteroids), that promotes muscle growth. The term includes all of the substances listed in s. 161.18 (7), and their esters, isomers, esters of isomers, salts and salts of esters, isomers and esters of isomers, that are theoretically possible under the specific chemical designation, and if such esters, isomers, esters of isomers, salts and salts of esters, isomers and esters of isomers promote muscle growth. CSB 2.010 Note(b) Except as provided in par. (c), the term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States secretary of health and human services for such administration.
CSB 2.010 Note(c) If a person prescribes, dispenses or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of par. (a).
